Cosmos Health (COSM) Total Current Liabilities (2014 - 2026)
Cosmos Health's (COSM) quarterly Total Current Liabilities came in at $34.8 million in Q2 2026, up 11.8% on a YoY basis from $31.2 million in Q2 2025, and up 2.25% quarter-over-quarter from $34.1 million in Q1 2026.
Analysis
Cosmos Health (COSM) Total Current Liabilities (2014 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported Total Current Liabilities for 13 consecutive years, with $34.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Current Liabilities rose 11.8% year-over-year to $34.8 million; the trailing twelve-month figure through Jun 2026 stood at $34.8 million (up 11.8% YoY), and the FY2025 full-year result was $38.3 million, up 48.59% from the prior year.
- Total Current Liabilities rose to $34.8 million in Q2 2026 per COSM's latest filing, from $34.1 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $38.5 million in Q3 2025 and bottomed at $18.6 million in Q1 2023.
- Historically, Total Current Liabilities has averaged $28.5 million across 5 years, with a median of $26.2 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Total Current Liabilities tumbled 43.6% in 2023, then surged 52.85% in 2025.
- Over 5 years, Total Current Liabilities stood at $21.7 million in 2022, then rose by 11.83% to $24.3 million in 2023, then grew by 5.9% to $25.8 million in 2024, then surged by 48.59% to $38.3 million in 2025, then dropped by 8.96% to $34.8 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $34.8 million, $34.1 million, and $38.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 15.65 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 6.35 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 1.66 Bn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 883.19 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 4.54 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 331.18 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 283.66 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 263.21 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 12.39 Mn |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn | 34.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.84 Mn |
| Mar 31, 2026 | 34.08 Mn |
| Dec 31, 2025 | 38.27 Mn |
| Sep 30, 2025 | 38.53 Mn |
| Jun 30, 2025 | 31.17 Mn |
| Mar 31, 2025 | 26.59 Mn |
| Dec 31, 2024 | 25.76 Mn |
| Sep 30, 2024 | 25.21 Mn |
| Jun 30, 2024 | 24.82 Mn |
| Mar 31, 2024 | 23.56 Mn |
| Dec 31, 2023 | 24.32 Mn |
| Sep 30, 2023 | 22.59 Mn |
| Jun 30, 2023 | 20.23 Mn |
| Mar 31, 2023 | 18.55 Mn |
| Dec 31, 2022 | 21.75 Mn |
| Sep 30, 2022 | 36.90 Mn |
| Jun 30, 2022 | 35.87 Mn |
| Mar 31, 2022 | 29.80 Mn |
| Dec 31, 2021 | 29.93 Mn |
| Sep 30, 2021 | 37.43 Mn |